about
Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategiesCell survival signalling through PPARδ and arachidonic acid metabolites in neuroblastomaCUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Studies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum.Naproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenaseSynthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolasePTGS-2-PTGER2/4 signaling pathway partially protects from diabetogenic toxicity of streptozotocin in mice.R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4.The safety, pharmacokinetics, and efficacy of intraocular celecoxib.5-Lipoxygenase inhibitors: a review of recent developments and patents.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).Inhibitors of the arachidonic acid cascade: interfering with multiple pathways.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase.New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib.Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LO.5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity.Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis.Liquid Chromatography-Mass Spectrometry-Based In Vitro Metabolic Profiling Reveals Altered Enzyme Expressions in Eicosanoid Metabolism.A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug.
P2860
Q27000132-AB094F9F-D924-46CE-9670-8D4C8E8C69BDQ28534569-B85BD658-BE1D-439A-AF96-D2B76EBA9FE0Q34437996-A3186137-C87B-4AB1-BAF3-16D6EC498B29Q34878474-2805453C-40F1-4F4A-A00E-503449B4AF07Q34938495-D562DE04-B5DD-4A68-B126-28E1CA103E31Q35762636-1872E540-ED91-4419-94F7-2F7E58327A41Q36047526-FA9671F4-0C53-480E-BDED-7CD3FD48079EQ37631485-5FE496BC-1861-4B94-BF01-3D7A20DBA551Q37636897-33FED0CF-7673-4359-A3D2-BC3F3996C420Q37697795-5C13F5D1-E240-487F-97AF-B7E6B0CB0B9CQ37995534-0DEE0EE3-C55D-4284-9A40-96929B7792BAQ38100199-BE236A05-1A1D-4ABF-896C-77241058877EQ38135433-F53B6E32-26E5-4BAC-8780-8FBCF94198AAQ38558587-1026EDFA-A1AA-4BF8-938B-2679F5FAB4C6Q38665189-E867812E-D9B0-4AFE-9667-695922E06F3AQ38723598-CA63355C-1D11-40ED-9422-D0C2A518F7D9Q38737298-66BD1D65-1E9C-4FA9-9647-4F7DFF6F4348Q38991781-1625F602-83CA-4906-93AE-B5EF36E5DA36Q39150746-F61E2B5C-78D8-46CD-B51A-7DA639D8BA45Q39652841-4520EFCE-FADF-418F-8709-10F804169970Q39906264-D9B10312-42FC-4929-BDFC-445D1A37E51BQ40939320-0A983335-3424-4C18-9291-B856109A1E47Q51740191-312B5E5B-0171-421A-BD15-95E93C67E244
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Celecoxib inhibits 5-lipoxygenase.
@ast
Celecoxib inhibits 5-lipoxygenase.
@en
Celecoxib inhibits 5-lipoxygenase.
@nl
type
label
Celecoxib inhibits 5-lipoxygenase.
@ast
Celecoxib inhibits 5-lipoxygenase.
@en
Celecoxib inhibits 5-lipoxygenase.
@nl
prefLabel
Celecoxib inhibits 5-lipoxygenase.
@ast
Celecoxib inhibits 5-lipoxygenase.
@en
Celecoxib inhibits 5-lipoxygenase.
@nl
P2093
P50
P1476
Celecoxib inhibits 5-lipoxygenase.
@en
P2093
Carlo Angioni
Carlo Pergola
Gerd Geisslinger
Julia Metzner
Lars Tausch
Michael Hoernig
Ovidiu Coste
Ronald Schmidt
Thorsten J Maier
P304
P356
10.1016/J.BCP.2008.07.009
P407
P577
2008-07-19T00:00:00Z